Fmoc-N(Hmb)-Gly-OH
CAS No. 148515-78-0
Fmoc-N(Hmb)-Gly-OH( —— )
Catalog No. M35896 CAS No. 148515-78-0
Fmoc-N(Hmb)-Gly-OH (Fmoc-(Hmb)Gly-OH) is a glycine derivative that can be used to synthesize peptide compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFmoc-N(Hmb)-Gly-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionFmoc-N(Hmb)-Gly-OH (Fmoc-(Hmb)Gly-OH) is a glycine derivative that can be used to synthesize peptide compounds.
-
DescriptionN-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2-hydroxy-4-methoxybenzyl)glycine is a Glycine (HY-Y0966) derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148515-78-0
-
Formula Weight433.45
-
Molecular FormulaC25H23NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(CN(CC(O)=O)C(=O)OCC2c3ccccc3-c3ccccc23)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.?
molnova catalog
related products
-
Efaproxiral Sodium
Efaproxiral Sodium , a synthetic allosteric modifier of hemoglobin, is utilized for brain metastases originating from breast cancer.
-
MLS000545091
MLS000545091 is a potent and selective human epithelial 15-lipoxygenase-2 (mixed-type) inhibitor.
-
CITCO
CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49?nM over pregnane X receptor (PXR), and no activity on other nuclear receptors.
Cart
sales@molnova.com